Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Disease × Biopsy × Clear all

Sponsor

Conditions

Breast Neoplasms 16 Lymphoma 12 Neoplasm Metastasis 9 Multiple Myeloma 9 Leukemia, Myeloid, Acute 8 Lung Neoplasms 7 Melanoma 6 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Lymphoma, Non-Hodgkin 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Carcinoma, Non-Small-Cell Lung 5 Neuroblastoma 4 Lymphoma, Follicular 4 Burkitt Lymphoma 4 Sarcoma, Kaposi 3 Prostatic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Myeloproliferative Disorders 3 Myelodysplastic Syndromes 3 Malignant Solid Neoplasm 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myelomonocytic, Acute 3 Leukemia 3 Hematologic Neoplasms 3 Head and Neck Neoplasms 3 HIV Infections 3 Fallopian Tube Neoplasms 3 Adenocarcinoma Of Esophagus 3 Wilms Tumor 2

Interventions

fluciclovine F-18 2 Positron-Emission Tomography 2 Injections 2 ioflupane 1 aflibercept 1 Water 1 Methylene Blue 1 Mammography 1 Drug Delivery Systems 1 Diagnosis, Computer-Assisted 1 Daunorubicin 1 Cytarabine 1 Control Groups 1 CPX-351 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡